11 May 2016 - - The pregnancy products market in the US was valued at USD 266.6m in 2014 and is projected to expand at a CAGR of 5.7% from 2015 to 2023 to reach USD 439.2m in 2023, according to new data from US-based Transparency Market Research.

Around 6.1m pregnancies were reported in the US in 2011. The common skin conditions occurring during pregnancy are separated into three categories: hormone-related changes, pre-existing, and pregnancy specific. Most of these occur especially in the second and third trimester of pregnancy.

Several products are available in the US in the form of cream, lotion, balm, gel, etc. for pregnant women and nursing mothers.

Based on product type, the pregnancy products market in the US has been segmented into stretch mark minimiser, body restructuring gel, toning/firming lotion, itching prevention cream, nipple protection cream, breast cream, stressed leg product, and others.

The market for these products has been extensively analyzed based on their utility, effectiveness, sales, and region-wise presence.

Increasing number of pregnant women in the US and rise in distribution channels such as hypermarkets, supermarkets, retail stores, and online stores are likely to fuel the growth of the market in the near future.

The pregnancy products market in the US is projected to expand at a CAGR of 5.7% during the forecast period from 2015 to 2023.

Additionally, growing awareness about pregnancy products among the female population in the US is likely to drive the market in the US.

However, factors such as side effects associated with pregnancy products could hamper the growth of the pregnancy products market.

The report offers a detailed analysis of this high growth and outlines a possible growth trajectory at the regional level in terms of value for each pregnancy product segment.

Stretch mark minimiser was the largest product segment of the market in 2014. Around 6.1m pregnancies were reported in the US in 2011.

Nearly 90% of the pregnant women develop stretch marks during pregnancy. Stretch marks are caused due to tearing of dermis.

Moreover, stretch marks are developed due to rapid change in weight, also influenced by the change in hormones during puberty, pregnancy, hormone replacement therapy, etc. These stretch marks can be treated with stretch mark minimiser creams and lotions.

Factors such as long-term use of stretch mark minimisers (minimum three to five months), rise in birth rate, and increase in the disposable income are set to drive the stretch mark minimiser segment.

However, according to some researchers, only a few products are available in the market that can prevent or reduce pregnancy stretch marks.

This is likely to hinder the growth of the stretch mark minimiser segment in the near future.

The others segment consists of moisturizing creams, face creams, body wash, and dark spot treatments. During pregnancy, motion sickness, hormone fluctuations, and stress lead to loss of water and vital nutrients from the body, resulting in flaky, dry, and itchy skin.

Moisturizing creams and lotions are used to treat these conditions.

The others segment is likely to expand at the highest CAGR during the forecast period due to long-term use of products, high disposable income, rising awareness among the female population, and increasing number of pregnancies.

The report has been compiled in order to update the stakeholders with the incumbent market dynamics through a graphical illustration and in-depth analysis of major segments for each region considered in the study scope.

Major players operating in the pregnancy products market in the US include Clarins Group, Expanscience Laboratories, Inc. (Mustela), Mama Mio US Inc., Noodle and Boo, Novena Maternity, Nine Naturals, LLC, and E.T. Browne Drug Co., Inc. (Palmers).

The key market players are actively involved in constant innovations and developments related to technology and application to cater to the multi-dimensional needs of the end-users in order to maintain their positions in the US.